Physiol Rev Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Physiol. Rev. 84: 361-384, 2004; doi:10.1152/physrev.00024.2003
0031-9333/04 $15.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (100)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by AVILA, J.
Right arrow Articles by HERNÁNDEZ, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by AVILA, J.
Right arrow Articles by HERNÁNDEZ, F.

Role of Tau Protein in Both Physiological and Pathological Conditions

JESÚS AVILA, JOSÉ J. LUCAS, MAR PÉREZ and FÉLIX HERNÁNDEZ

Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Facultad de Ciencias, Campus de Cantoblanco, Madrid, Spain

Avila, Jesús, José J. Lucas, Mar Pérez, and Félix Hernández. Role of Tau Protein in Both Physiological and Pathological Conditions. Physiol Rev 84: 361–384, 2004; 10.1152/physrev.00024.2003.—The morphology of a neuron is determined by its cytoskeletal scaffolding. Thus proteins that associate with the principal cytoskeletal compo-nents such as the microtubules have a strong influence on both the morphology and physiology of neurons. Tau is a microtubule-associated protein that stabilizes neuronal microtubules under normal physiological conditions. However, in certain pathological situations, tau protein may undergo modifications, mainly through phosphorylation, that can result in the generation of aberrant aggregates that are toxic to neurons. This process occurs in a number of neurological disorders collectively known as tauopathies, the most commonly recognized of which is Alzheimer's disease. The purpose of this review is to define the role of tau protein under normal physiological conditions and to highlight the role of the protein in different tauopathies.

Address for reprint requests and other correspondence: J. Avila, Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Facultad de Ciencias, Campus de Cantoblanco, Universidad Autónoma de Madrid, 28049 Madrid, Spain (E-mail: ).




This article has been cited by other articles:


Home page
 J. Neurosci.Home page
E. Planel, P. Krishnamurthy, T. Miyasaka, L. Liu, M. Herman, A. Kumar, A. Bretteville, H. Y. Figueroa, W. Haung Yu, R. A. Whittington, et al.
Anesthesia-Induced Hyperphosphorylation Detaches 3-Repeat Tau from Microtubules without Affecting Their Stability In Vivo
J. Neurosci., November 26, 2008; 28(48): 12798 - 12807.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Bravo, M. Arimon, J. J. Valle-Delgado, R. Garcia, N. Durany, S. Castel, M. Cruz, S. Ventura, and X. Fernandez-Busquets
Sulfated Polysaccharides Promote the Assembly of Amyloid {beta}1-42 Peptide into Stable Fibrils of Reduced Cytotoxicity
J. Biol. Chem., November 21, 2008; 283(47): 32471 - 32483.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. A. Rodriguez-Navarro, A. Gomez, I. Rodal, J. Perucho, A. Martinez, V. Furio, I. Ampuero, M. J. Casarejos, R. M. Solano, J. G. de Yebenes, et al.
Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice
Hum. Mol. Genet., October 15, 2008; 17(20): 3128 - 3143.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. Planel, Y. Tatebayashi, T. Miyasaka, L. Liu, L. Wang, M. Herman, W. H. Yu, J. A. Luchsinger, B. Wadzinski, K. E. Duff, et al.
Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms
J. Neurosci., December 12, 2007; 27(50): 13635 - 13648.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Goni-Oliver, J. J. Lucas, J. Avila, and F. Hernandez
N-terminal Cleavage of GSK-3 by Calpain: A NEW FORM OF GSK-3 REGULATION
J. Biol. Chem., August 3, 2007; 282(31): 22406 - 22413.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
M. F. Mehler and J. S. Mattick
Noncoding RNAs and RNA Editing in Brain Development, Functional Diversification, and Neurological Disease
Physiol Rev, July 1, 2007; 87(3): 799 - 823.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
E. R. Marcantonio, J. L. Rudolph, D. Culley, G. Crosby, D. Alsop, and S. K. Inouye
Review Article: Serum Biomarkers for Delirium
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1281 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. Engel, F. Hernandez, J. Avila, and J. J. Lucas
Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.
J. Neurosci., May 10, 2006; 26(19): 5083 - 5090.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Cripps, S. N. Thomas, Y. Jeng, F. Yang, P. Davies, and A. J. Yang
Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation
J. Biol. Chem., April 21, 2006; 281(16): 10825 - 10838.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Z. Berger, B. Ravikumar, F. M. Menzies, L. G. Oroz, B. R. Underwood, M. N. Pangalos, I. Schmitt, U. Wullner, B. O. Evert, C. J. O'Kane, et al.
Rapamycin alleviates toxicity of different aggregate-prone proteins
Hum. Mol. Genet., February 1, 2006; 15(3): 433 - 442.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. Carro, C. Spuch, J. L. Trejo, D. Antequera, and I. Torres-Aleman
Choroid Plexus Megalin Is Involved in Neuroprotection by Serum Insulin-Like Growth Factor I
J. Neurosci., November 23, 2005; 25(47): 10884 - 10893.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J.-M. Gallo, P. Jin, C. A. Thornton, H. Lin, J. Robertson, I. D'Souza, and W. W. Schlaepfer
The Role of RNA and RNA Processing in Neurodegeneration
J. Neurosci., November 9, 2005; 25(45): 10372 - 10375.
[Full Text] [PDF]

Home page
 FASEB J.Home page
A. P. Wasilewska-Sampaio, M. S. Silveira, O. Holub, R. Goecking, F. C. A. Gomes, V. M. Neto, R. Linden, S. T. Ferreira, and F. G. De Felice
Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound
FASEB J, October 1, 2005; 19(12): 1627 - 1636.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H. Lohi, L. Ianzano, X.-C. Zhao, E. M. Chan, J. Turnbull, S. W. Scherer, C. A. Ackerley, and B. A. Minassian
Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy
Hum. Mol. Genet., September 15, 2005; 14(18): 2727 - 2736.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. R. Williams, R. de Silva, D. C. Paviour, A. Pittman, H. C. Watt, L. Kilford, J. L. Holton, T. Revesz, and A. J. Lees
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
Brain, June 1, 2005; 128(6): 1247 - 1258.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Shi, G. Zhao, D. Qiu, W. R. Godfrey, H. Vogel, T. A. Rando, H. Hu, and P. N. Kao
NF90 Regulates Cell Cycle Exit and Terminal Myogenic Differentiation by Direct Binding to the 3'-Untranslated Region of MyoD and p21WAF1/CIP1 mRNAs
J. Biol. Chem., May 13, 2005; 280(19): 18981 - 18989.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
G. V. W. Johnson and W. H. Stoothoff
Tau phosphorylation in neuronal cell function and dysfunction
J. Cell Sci., November 15, 2004; 117(24): 5721 - 5729.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.